Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Vera Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
   10-K10-KS-1
Revenues  34.652.50.0
            Revenue growth  -34.1%  
Cost of goods sold  0.00.00.0
Gross profit  34.652.50.0
            Gross margin  100.0%100.0% 
Selling, general and administrative   [+]11.94.04.4
Research and development  22.545.27.3
Other operating expenses  34.452.2 
EBITDA   [+]-34.2-49.0-11.2
            EBITDA margin  -99.0%-93.3% 
Depreciation and amortization  0.20.30.5
EBIT   [+]-34.4-49.2-11.7
            EBIT margin  -99.5%-93.8% 
Non-recurring items   3.00.3
Interest expense, net   [+]0.00.2-0.1
Other income (expense), net   [+]1.8-1.0 
Pre-tax income  -32.6-53.4-11.9
Income taxes  0.00.00.0
Net income  -32.6-53.4-11.9
            Net margin  -94.3%-101.8% 
   
Basic EPS   [+]($2.43)($166.93)($40.14)
Diluted EPS   [+]($2.43)($166.93)($40.14)
   
Shares outstanding (basic)   [+]13.40.30.3
Shares outstanding (diluted)   [+]13.40.30.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy